Search publications
44 results found
-
ACM launches market study into the Platform-to-Business Regulation
The Netherlands Authority for Consumers and Markets (ACM) will launch a study into how online platform companies deal with the rules laid down in the Platform-to-Business Regulation (P2B Regulation), and into the problems that businesses that are active … -
Decision to fine Leadiant for excessive price of CDCA drug
After an investigation ACM has determined that manufacturer Leadiant abused its dominant position by charging an excessive price for its prescription drug. CDCA-Leadiant. This occurred in the period from June 2017 through December 2019. For this violation … -
ACM imposes fine on drug manufacturer Leadiant for CDCA’s excessive price
The Netherlands Authority for Consumers and Markets (ACM) has established that drug manufacturer Leadiant charged far too high a price for its prescription drug CDCA-Leadiant. As such, Leadiant abused its dominant position. ACM has therefore imposed a … -
Closure of the investigation into payment apps confirms need for new rules
The Netherlands Authority for Consumers and Markets (ACM) will close its investigation into payment apps’ access to NFC technology installed in devices such as smartphones. NFC technology offers the ability to make contactless payments using smartphones … -
New European competition rules for Big Tech companies can be even more effective
The European association of competition authorities, the European Competition Network (ECN), has released a joint statement about the proposal for new European competition rules for companies that act as digital gatekeepers, the so-called Digital Markets … -
ACM can continue its investigation into the Apple App Store
The investigation of the Netherlands Authority for Consumers and Markets (ACM) into Apple’s App Store complements the investigations of the European Commission into the App Store. All of these investigations can be conducted next to each other, so ACM can … -
ACM extends its investigation into orphan drug CDCA-Leadiant
The Netherlands Authority for Consumers and Markets (ACM) extends its investigation into the orphan drug CDCA manufactured by Leadiant. The investigation focuses on the question whether the manufacturer abuses a dominant position in the pricing of the … -
ACM’s oversight during the Coronavirus crisis
This is an updated version of ACM’s statement published on 18 March. The current Coronavirus (COVID-19) outbreak has far-reaching effects on people and businesses. These are extraordinary times. ACM is closely monitoring economic developments, and is … -
ACM has appointed five new Non-Governmental Advisors
The Netherlands Authority for Consumers and Markets (ACM) has appointed five new Non-Governmental Advisors (NGAs). One of their duties is to help promote international cooperation in the world of competition. The NGAs are experts who come from academia, … -
European competition authorities and oversight during the Coronavirus crisis
The joint European competition authorities have released a statement on how they will deal with far-reaching collaborations that companies wish to launch in order to combat the Coronavirus (COVID-19) crisis. The Netherlands Authority for Consumers and …